Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease

Virology

Volumn 232, Issue 1, 1997, Pages 1-12

  Da Costa, Xavier J ^a   Bourne, Nigel ^b   Stanberry, Lawrence R ^b   Knipe, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; GENITAL HERPES; GUINEA PIG; HERPES SIMPLEX VIRUS 2; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0030917882     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8564     Document Type: Article

References (48)

1. Aurelian L., Smith C. C., Wachsman M., Paoletti E. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D. Rev. Infect. Dis. 13:1991;S924-934.
2. Bourne N., Stanberry L. R., Berstein D. I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:1996;800-807.
3. Boursnell M. E. G., Entwisle C., Blakeley D., Roberts C., Duncan I. A., Chisholm S. E., Martin G. M., Jennings R., Ni Challanain D., Sobek I., Inglis S. C., McLean C. S. A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J. Infect. Dis. 175:1997;16-25.
4. Challberg M. D. A method for identifying the viral genes required for herpesvirus DNA replication. Proc. Natl. Acad. Sci. USA. 83:1986;9094-9098.
5. Chen Y. M., Knipe D. M. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription. Virology. 221:1996;281-290.
6. Chenet-Monte C., Mohammad F., Celluzzi C. M., Schaffer P. A., Farber F. E. Herpes simplex virus gene products involved in the induction of chromosomal aberrations. Virus Res. 6:1986;245-260.
7. Conley A. J., Knipe D. M., Jones P. C., Roizman B. Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of gamma polypeptides. J. Virol. 37:1981;191-206.
8. Davison A. J., Marsden H. S., Wilkie N. M. One functional copy of the long terminal repeat gene specifying the immediate-early polypeptide IE 110 suffices for a productive infection of human foetal lung cells by herpes simplex virus. J. Gen. Virol. 55:1981;179-191.
9. de Bruyn Kops A., Knipe D. M. Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein. Cell. 55:1988;857-868.
10. Fuller S. A., Takahashi M., Jurrell J. G. R. Current Protocols in Molecular Biology. 1995;Wiley, New York. p. 11.5.1-11.5.3.
11. Gao M., Knipe D. M. Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein. J. Virol. 63:1989;5258-5267.
12. Gao M., Knipe D. M. Potential role for herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression. J. Virol. 65:1991;2666-2675.
13. Ghiasi H., Cai S., Slanina S., Nesburn a. B., Wechsler S. L. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28:1995;147-157.
14. Godowski P. J., Knipe D. M. Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes. J. Virol. 55:1985;357-365.
15. Godowski P. J., Knipe D. M. Transcriptional control of herpesvirus gene expression: Gene functions required for positive and negative regulation. Proc. Natl. Acad. Sci. USA. 83:1986;256-260.
16. Graham F. L., Van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-457.
17. Heilbronn R., Zur Hausen H. A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome. J. Virol. 63:1989;3683-3692.
18. Katz J. P., Bodin E. T., Coen D. M. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J. Virol. 64:1990;4288-4295.
19. Knipe D. M. The role of viral and cellular nuclear proteins in herpes simplex virus replication. Adv. Virus Res. 37:1989;85-123.
20. Knipe D. M., DaCosta X., Morrison L. A. Immunization against genital herpes disease: Factors in the design of a replication-impaired vaccine. Chanock R. M., Brown F., Ginsberg H. S., Norrby E. Vaccines 1996. 1996;13-17 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
21. Knipe D. M., Ruyechan W. T., Roizman B. Molecular genetics of herpes simplex virus. III. Fine mapping of a genetic locus determining resistance to phosphonoacetate by two methods of marker transfer. J. Virol. 29:1979;698-704.
22. Kriesel J. D., Spruance S. L., Daynes R. A., Araneo B. A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Infect. Dis. 173:1996;536-541.
23. Leopardi R., Roizman B. The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc. Natl. Acad. Sci. USA. 93:1996;9583-9587.
24. Marsden H. S., Stow N. D., Preston V. G., Timbury M. C., Wilkie N. M. Physical mapping of herpes simplex virus-induced polypeptides. J. Virol. 28:1978;624-642.
25. McDermott M. R., Graham F. L., Hanke T., Johnson D. C. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology. 169:1989;244-247.
26. McDermott M. R., Smiley J. R., Leslie P., Brais J., Rudzroga H. E., Bienenstock J. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:1984;747-773.
27. McGeoch D. J., Dalrymple M. A., Davison A. J., Dolan A., Frame M. C., McNab D., Perry L. J., Scott J. E., Taylor P. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1988;1531-1574.
28. Meignier B., Jourdier T. M., Norrild B., Pereira L., Roizman B. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: Protection against challenge with virulent virus. J. Infect. Dis. 155:1987;921-930.
29. Meignier B., Longnecker R., Mavromara-Nazos P., Sears A. E., Roizman B. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology. 162:1988a;251-254.
30. Meignier B., Longnecker R., Roizman B. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: Construction and evaluation in rodents. J. Infect. Dis. 158:1988b;602-614.
31. Meignier B., Martin B., Whitley R. J., Roizman B. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus. J. Infect. Dis. 162:1990;313-321.
32. Mertz G. J., Ashley R., Burke R. L., Benedetti J., Critchlow C., Jones C. C., Corey L. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J. Infect. Dis. 161:1990;653-660.
33. Morrison L. A., Knipe D. M. Immunization with replication- defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68:1994;689-696.
34. Morrison L. A., Knipe D. M. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology. 220:1996;402-413.
35. Morse L. S., Pereira L., Roizman B., Schaffer P. A. Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. J. Virol. 26:1978;389-410.
36. Nguyen L. H., Knipe D. M., Finberg R. W. Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J. Virol. 66:1992;7067-7072.
37. Orberg P. K., Schaffer P. A. Expression of herpes simplex virus type 1 major DNA-binding protein, ICP8, in transformed cell lines: Complementation of deletion mutants and inhibition of wild-type virus. J. Virol. 61:1987;1136-1146.
38. Rawls W. E., Laurel D., Melnick J. L., Glicksman J. M., Kaufman R. H. A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of herpesviruses with distinct antigenic properties. Am. J. Epidemiol. 87:1968;647-655.
39. Ruyechan W. T., Morse L. S., Knipe D. M., Roizman B. Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells. J. Virol. 29:1979;677-697.
40. Spang A. E., Godowski P. J., Knipe D. M. Characterization of herpes simplex virus 2 temperature-sensitive mutants whose lesions map in or near the coding sequences for the major DNA- binding protein. J. Virol. 45:1983;332-342.
41. Stanberry L. R. Herpes simplex virus vaccines in animals: The guinea pig vaginal model. Rev. Infect. Dis. 13:1991;S920-923.
42. Stanberry L. R. Herpes immunization - On the threshold. J. Eur. Acad. Dermatol. Venerol. 1996.
43. Stanberry L. R., Bernstein D. I., Burke R. L., Pachl C., Myers M. G. Recombinant herpes simplex virus glycoproteins: Protection against initial and recurrent genital herpes. J. Infect. Dis. 155:1987;914-920.
44. Stanberry L. R., Kern E. R., Richards J. T., Abbott T. M., Overall J. C. Jr. Genital herpes in guinea pigs: Pathogenesis of the primary infection and description of recurrent disease. J. Infect. Dis. 146:1982;397-404.
45. Stanberry L. R., Kern E. R., Richards J. T., Overall J. C. Jr. Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology. 24:1985a;226-231.
46. Stanberry L. R., Kit S., Myers M. G. Thymidine kinase- deficient herpes simplex virus type 2 genital infection in guinea pigs. J. Virol. 55:1985b;322-328.
47. Walboomers J. M., ter Schegget J. A new method for the isolation of herpes simplex virus type 2 DNA. Virology. 74:1976;256-258.
48. Weller S. K. Genetic analysis of HSV-1 genes required for genome replication. Wagner E. K. Herpesvirus Transcription and Its Regulation. 1991;105-136 CRC Press, Boca Raton.